CJC-1295 + Ipamorelin
CJC-1295 + Ipamorelin
This pairing represents the most researched GH secretagogue combination, activating growth hormone release through two distinct receptor pathways simultaneously. Human clinical data shows CJC-1295 produces 2–10 fold increases in GH with sustained IGF-1 elevation for up to 28 days. Ipamorelin adds precise GH pulse stimulation via the ghrelin receptor without raising cortisol — a key selectivity advantage confirmed in research. Studies demonstrate their combined use produces greater and more physiologically natural GH output than either compound in isolation.
Supplied as research-grade lyophilised peptide blend. Requires reconstitution with bacteriostatic water prior to use. For research purposes only.
Research Stack Builder
Build Your Research Stack
Curated combinations based on what researchers actually stack — backed by published data, priced to save.
Stack with CJC-1295 + Ipamorelin
Why researchers stack these
- 01GH axis covered via three distinct pathways
- 02Direct tissue repair alongside GH elevation
- 03Collagen synthesis completes the protocol
Full research context
CJC-1295 and Ipamorelin stimulate GH release through GHRH receptor and ghrelin receptor pathways respectively — producing synergistic GH pulses. BPC-157 and TB-500 are frequently added to study how GH elevation interacts with direct tissue repair signalling; many researchers observe amplified recovery when both systems are active simultaneously. Tesamorelin adds a third GHRH-based input for researchers studying sustained growth hormone patterns. GHK-Cu rounds out the protocol with collagen support and extracellular matrix repair.
Recovery & Repair Protocol
The most studied peptide combination for tissue repair, injury recovery & musculoskeletal healing
Why researchers stack these
- 01Non-competing structural repair pathways
- 02BPC-157 angiogenesis + TB-500 satellite cell activation
- 03GHK-Cu adds the extracellular matrix layer both lack
Full research context
BPC-157 and TB-500 are the two most frequently co-researched repair peptides in published literature, acting through complementary mechanisms — BPC-157 via nitric oxide pathways and angiogenesis, TB-500 via actin-sequestering and satellite cell activation. GHK-Cu rounds out the stack by supporting collagen synthesis and the extracellular matrix that both compounds do not directly address, while reducing the oxidative load that slows tissue recovery.
Metabolic & Body Recomposition
Most popular Peptide Pal stack — two non-competing fat loss axes with skin integrity support
Why researchers stack these
- 01GLP-1 triple agonism + GH axis — two distinct fat loss pathways
- 02Skin integrity preserved throughout recomposition
- 03Most purchased together on Peptide Pal
Full research context
Retatrutide and Tesamorelin address body composition through two non-competing mechanisms. Retatrutide's triple receptor agonism drives broad metabolic improvement and appetite regulation; Tesamorelin is FDA-approved for visceral adipose reduction through the growth hormone axis — a distinct mechanism. GHK-Cu supports skin integrity during recomposition; rapid fat loss without collagen support produces visible skin laxity that is far harder to address after the fact.
Cognitive Performance Stack
Neuropeptides studied for synergistic cognitive enhancement, focus & stress resilience — no sedation
Why researchers stack these
- 01BDNF stimulation balanced by GABA modulation
- 02Focus without anxiety — three non-competing pathways
- 03NAD+ fuels the neuronal energy demand
Full research context
Semax and Selank are registered pharmaceuticals with distinct mechanisms. Semax drives BDNF upregulation and cortical processing speed; Selank reduces the stress-induced cognitive interference that can blunt that effect, without sedation or dependency. NAD+ provides the cellular energy substrate that enhanced neuronal activity demands — researchers consistently report that this combination delivers balanced cognitive performance that neither compound achieves alone.
Skin & Glow Protocol
Collagen synthesis, antioxidant protection & melanin research in one comprehensive skin stack
Why researchers stack these
- 01Collagen, antioxidant & pigmentation — three skin pillars
- 02Tyrosinase inhibition counterbalances MC1R agonism for pathway research
- 03Structural integrity maintained alongside brightening
Full research context
GHK-Cu stimulates collagen synthesis and modulates over 4,000 genes involved in skin repair and inflammatory control — addressing the structural layer. Glutathione reduces oxidative stress and inhibits tyrosinase, producing measurable skin brightening with 30–35% tissue GSH increases confirmed in human RCTs. MT2 drives eumelanin synthesis via MC1R agonism, and researchers frequently combine it with Glutathione to study the interplay between melanocortin-driven pigmentation and tyrosinase inhibition simultaneously. Together these three represent the most comprehensive skin research protocol available.
Cellular Longevity Protocol
Three compounds that decline together with age — combined restoration for mitochondrial & cellular health
Why researchers stack these
- 01All three decline together with age — parallel restoration
- 02Mitochondrial energy, AMPK signalling & antioxidant protection
- 03Most complete cellular longevity protocol available
Full research context
NAD+, MOTS-c, and glutathione all decline measurably with age through parallel but distinct pathways. NAD+ restores sirtuin and PARP function essential for mitochondrial biogenesis and DNA repair — declining up to 50% by age 60. MOTS-c is the mitochondria-derived peptide that activates AMPK signalling and declines alongside NAD+; their combined restoration is the most researched longevity intervention. Glutathione provides the antioxidant protection that prevents cellular damage during the heightened metabolic activity that NAD+ and MOTS-c restoration drives — completing what researchers describe as the foundational cellular longevity triad.
Research & Studies
Peer-reviewed research supporting CJC-1295 + Ipamorelin
CJC-1295 Produces Sustained GH and IGF-1 Elevation in Healthy Human Adults
A dose-escalation study in healthy adult human volunteers demonstrated that a single injection of CJC-1295 produced dose-dependent increases in mean GH concentrations of 2- to 10-fold above baseline, with elevated GH and IGF-1 levels maintained for 6 days post-injection due to the compound’s drug affinity complex technology extending its circulating half-life. After multiple doses, IGF-1 levels were elevated by 1.5- to 3-fold above baseline and remained elevated for up to 28 days, demonstrating the first human evidence of prolonged GHRH receptor activation without the continuous infusion required by natural GHRH.
Ipamorelin: Highly Selective GH Secretagogue with Clean Safety Profile in Research
Raun et al. characterised ipamorelin as a novel, highly selective growth hormone secretagogue receptor (GHS-R) agonist that stimulates GH release via the ghrelin receptor pathway independently of GHRH. In contrast to earlier GH secretagogues, ipamorelin produced potent GH release without stimulating ACTH, cortisol, or prolactin secretion at effective doses — a critical distinction establishing its superior selectivity profile for isolated GH axis stimulation. The compound demonstrated a robust GH pulse with rapid onset and clean return to baseline, making it the most selective GHS-R agonist characterised at the time.
Dual Pathway GH Stimulation: Mechanistic Rationale for the CJC-1295 and Ipamorelin Combination
CJC-1295 and ipamorelin act on two mechanistically distinct but synergistic GH secretory pathways — CJC-1295 amplifies GH pulse magnitude via pituitary GHRH receptors while ipamorelin independently triggers GH release via GHS-R, the ghrelin receptor. Ionescu and Frohman’s research characterised how simultaneous activation of both pathways produces significantly greater and more physiologically natural GH output than either compound alone, with CJC-1295 extending pulse duration and ipamorelin adding pulse frequency. This complementary dual mechanism forms the scientific basis for their combined use in GH axis research.